Clinical Trials on Skin Expander

Total 50456 results

Janssen Research & Development, LLC

Completed

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab (NAVIGATE)

Psoriasis

United States, Poland, United Kingdom, Germany, Taiwan, Spain, Australia, Canada, Korea, Republic of, Russian Federation
Centocor, Inc.

Completed

A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis

Psoriasis

United States
Janssen Pharmaceutical K.K.

Completed

A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis

Psoriasis

Japan
Illumicure Inc

Unknown

Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis

Psoriasis

United States
Genentech, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp (SCALP)

Psoriasis
Taro Pharmaceuticals USA

Completed

Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis

Psoriasis
Eli Lilly and Company

Completed

A Safety Study of Mirikizumab (LY3074828)

Psoriasis

Canada
GlaxoSmithKline

Completed

Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis

Psoriasis

Germany
Merck Sharp & Dohme LLC

Completed

The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)

Psoriasis
University College Dublin

Completed

Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP) (DINUP)

Psoriasis

Ireland
Bausch Health Americas, Inc.

Completed

Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects

Psoriasis

United States, Australia, New Zealand
Bayer

Completed

BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

Psoriasis

Germany
Genentech, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

Psoriasis
Janssen Biotech, Inc.

Completed

A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis (PSTELLAR)

Psoriasis

United States
Merck KGaA, Darmstadt, Germany

Completed

Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects

Psoriasis

Germany
Leon Kircik, M.D.
Stiefel, a GSK Company

Completed

Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis

Psoriasis

United States
Biopolis S.L.
Korott, S.L.

Completed

Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients

Psoriasis

Spain
University of Pittsburgh
LEO Pharma

Completed

A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy

Psoriasis

United States
Seoul National University Hospital

Completed

Comparison Study of Psoriasis Severity Assessment Tools

Psoriasis

Korea, Republic of
University of Aberdeen
NHS Grampian

Completed

Anti-psoriatic Effect of TL01 Light Therapy

Psoriasis

United Kingdom
Prothena Biosciences Limited

Completed

Single Ascending Dose Study of PRX003 in Healthy Subjects

Psoriasis

United States
Applied Biology, Inc.

Completed

Photocil (Topical) for the Treatment of Psoriasis Vulgaris

Psoriasis

United States
Hoffmann-La Roche

Completed

A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Psoriasis

Brazil
shmuel fuchs

Withdrawn

Influence of Atorvastatin on Psoriasis Severity and Endothelial Function

Psoriasis

Israel
Merck Sharp & Dohme LLC

Completed

Assessment of Long-Term Infliximab for Psoriasis (P05319) (REALITY)

Psoriasis
Maruho North America Inc.

Completed

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

Psoriasis

United States
Maruho North America Inc.

Completed

Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

Psoriasis

United States
Merck Sharp & Dohme LLC

Completed

Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047) (PHODYPSO)

Psoriasis
Pfizer

Completed

Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings

Psoriasis

Germany
Catholic University of the Sacred Heart

Completed

Individualized Medical Training and Calcipotriol and Betamethasone Dipropionate Gel in Plaque Psoriasis

Psoriasis
Illumicure Inc

Unknown

Luma Light System Proof of Concept Study in Subjects With Mild to Moderate Psoriasis

Psoriasis

United States
Medimix Specialty Pharmacy, LLC

Suspended

Efficacy of Novel Drug-combinations for Relief of Psoriasis (ENDURE)

Psoriasis

United States
LEO Pharma
Quintiles, Inc.

Completed

LEO 90105 Ointment in Japanese Subjects With Psoriasis

Psoriasis

Japan
LEO Pharma

Completed

Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis

Psoriasis

United States
medac GmbH
PPD

Completed

Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen

Psoriasis

United States
Janssen Research & Development, LLC

Completed

A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)

Psoriasis

France, Ukraine, United Kingdom, Germany, Portugal, Canada, Belgium, Russian Federation, Hungary, Sweden
Janssen Research & Development, LLC

Completed

An Exploratory Genetic Study in Participants With Psoriasis

Psoriasis

United States, Canada
University of Rochester
National Center for Complementary and Integrative Health (NCCIH)

Completed

Improving Psoriasis Through Health and Well-Being

Psoriasis

United States
Taro Pharmaceuticals USA

Completed

Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study

Psoriasis

United States
Amgen

Completed

Moderate to Severe Plaque Psoriasis With Scalp Involvement

Psoriasis
Janssen Pharmaceutical K.K.

Completed

An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis

Psoriasis

Japan
St Vincent's University Hospital, Ireland

Unknown

Comparing Mindfulness Based Cognitive Therapy and Mindfulness Based Self-compassion Therapy in a Psoriasis Sample

Psoriasis

Ireland
Genentech, Inc.

Completed

A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g

Psoriasis
Genentech, Inc.

Completed

A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies

Psoriasis
Medical University of Graz

Unknown

UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis

Psoriasis

Austria
Genentech, Inc.

Completed

A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy

Psoriasis
Bispebjerg Hospital
AbbVie; University of Copenhagen

Unknown

TL1A Expression in Psoriatic Skin

Psoriasis

Denmark
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

Psoriasis
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer; Immunex Corporation

Completed

Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects

Psoriasis
Amgen

Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis

Psoriasis

New Zealand, Australia

3

Subscribe